Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01480440

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System Used in Primary or Revision Reverse Total Shoulder Arthroplasty

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

Detailed description

The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty. This will be done by analysis of standard scoring systems, radiographs and adverse event records. Data will be collected and analyzed to monitor pain, function, and survivorship and to confirm the performance of the Trabecular Metal Reverse Shoulder System. Performance will be evaluated by monitoring the frequency and incidence of adverse events as well as by assessment of the overall pain and functional performances, survivorship, health status and radiographic parameters of all enrolled study subjects who receive the Trabecular metal Reverse Shoulder System. Pain and functional performance will be measured using the American Shoulder and Elbow Surgeons (ASES) Shoulder Assessment and the Single Assessment Numeric Evaluation (SANE), survivorship will be based on removal or intended removal of the device, health status will be determined by evaluation of the Short Form Survey12 (SF-12) as well as Adverse Events (AEs) and radiographic parameters analysis of x-rays.

Conditions

Interventions

TypeNameDescription
DEVICETrabecular Metal Reverse Shoulder SystemTrabecular Metal Reverse Shoulder System used in primary or revision total shoulder arthroplasty

Timeline

Start date
2011-01-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2011-11-28
Last updated
2025-10-29

Locations

5 sites across 2 countries: United States, United Kingdom

Regulatory

Source: ClinicalTrials.gov record NCT01480440. Inclusion in this directory is not an endorsement.